2025
SJR Q3
JCR Q3 · 2,5
OA
47 matched articles
ESCI
Journal detail
Reumatologia
- Publisher
- Termedia Publishing House Ltd.
- Country
- Poland · Eastern Europe
- Type
- journal
- ISSN
-
0034623320849834
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,62
- Quartile Q3
- H-Index 33
- Cites/doc 1,95
- Docs (3y) 215
- Cites (3y) 419
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF —
- JCI 0,43
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Immunology Q3
- Immunology and Allergy Q3
- Rheumatology Q3
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,62 | 2,5 | — | 0,43 | Q3 | 33 |
| 2024 | Q3 | Q3 | 0,5 | 1,7 | — | 0,38 | Q3 | 30 |
| 2023 | Q3 | Q3 | 0,379 | 1,4 | — | 0,31 | Q4 | 30 |
| 2022 | Q3 | — | 0,404 | — | — | — | — | 30 |
| 2021 | Q3 | — | 0,442 | — | — | — | — | 30 |
| 2020 | Q3 | — | 0,45 | — | — | — | — | 30 |
| 2019 | Q3 | — | 0,396 | — | — | — | — | 30 |
| 2017 | Q4 | — | 0,171 | — | — | — | — | 30 |
| 2016 | Q4 | — | 0,124 | — | — | — | — | 30 |
| 2015 | Q4 | — | 0,124 | — | — | — | — | 30 |
| 2014 | Q4 | — | 0,117 | — | — | — | — | 30 |
| 2013 | Q4 | — | 0,127 | — | — | — | — | 30 |
| 2012 | Q4 | — | 0,129 | — | — | — | — | 30 |
| 2011 | Q4 | — | 0,115 | — | — | — | — | 30 |
| 2010 | Q4 | — | 0,115 | — | — | — | — | 30 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | RHEUMATOLOGY | ESCI | Q3 | Q3 | 31/58 |
| 2024 | RHEUMATOLOGY | ESCI | Q3 | Q3 | 40/58 |
| 2023 | RHEUMATOLOGY | ESCI | Q3 | Q4 | 40/57 |